{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:38:47Z","timestamp":1790699927376,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              The\n              <jats:styled-content style=\"fixed-case\">ABC<\/jats:styled-content>\n              \u2010stroke score (age, biomarkers [N\u2010terminal fragment B\u2010type natriuretic peptide, high\u2010sensitivity troponin], and clinical history [prior stroke\/transient ischemic attack]) was proposed to predict stroke in atrial fibrillation (\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              ). This score was derived\/validated in 2 clinical trial cohorts in which patients with AF were highly selected and carefully followed\u2010up. However, the median follow\u2010up was 1.9\u00a0years in the trial cohort; therefore, its long\u2010term predictive performance remains uncertain. This study aimed to compare the long\u2010term predictive performances of the\n              <jats:styled-content style=\"fixed-case\">ABC<\/jats:styled-content>\n              \u2010stroke and\n              <jats:styled-content style=\"fixed-case\">CHA<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n              c (cardiac failure or dysfunction, hypertension, age \u226575 [doubled], diabetes mellitus, stroke [doubled]\u2014vascular disease, age 65 to 74\u00a0years and sex category [female]) scores in a cohort of anticoagulated patients with AF.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              We recruited 1125 consecutive patients with AF who were stable on vitamin K antagonists and followed\u2010up for a median of 6.5\u00a0years.\n              <jats:styled-content style=\"fixed-case\">ABC<\/jats:styled-content>\n              \u2010stroke and\n              <jats:styled-content style=\"fixed-case\">CHA<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n              c (cardiac failure or dysfunction, hypertension, age \u226575 [doubled], diabetes mellitus, stroke [doubled]\u2014vascular disease, age 65 to 74\u00a0years and sex category [female]) scores were calculated and compared. Median\n              <jats:styled-content style=\"fixed-case\">CHA<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n              c and\n              <jats:styled-content style=\"fixed-case\">ABC<\/jats:styled-content>\n              \u2010stroke scores were 4 (interquartile range 3\u20135) and 9.1 (interquartile range 7.3\u201311.3), respectively. There were 114 ischemic strokes (1.55% per year) at 6.5\u00a0years. The C\u2010index of\n              <jats:styled-content style=\"fixed-case\">ABC<\/jats:styled-content>\n              \u2010stroke at 3.5\u00a0years was significantly higher than\n              <jats:styled-content style=\"fixed-case\">CHA<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n              c (0.663 versus 0.600,\n              <jats:italic>P<\/jats:italic>\n              =0.046), but both C\u2010indexes were nonsignificantly different at 6.5\u00a0years. Integrated discrimination improvement showed a small improvement (&lt;2%) in sensitivity at 3.5 and 6.5\u00a0years with\n              <jats:styled-content style=\"fixed-case\">ABC<\/jats:styled-content>\n              \u2010stroke. For\n              <jats:styled-content style=\"fixed-case\">ABC<\/jats:styled-content>\n              \u2010stroke, net reclassification improvement was nonsignificantly different at 3.5\u00a0years, and showed a negative reclassification at 6.5\u00a0years compared with\n              <jats:styled-content style=\"fixed-case\">CHA<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n              c. Decision curve analyses did not show a marked improvement in clinical usefulness of the\n              <jats:styled-content style=\"fixed-case\">ABC<\/jats:styled-content>\n              \u2010stroke score over the\n              <jats:styled-content style=\"fixed-case\">CHA<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n              c score.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              In anticoagulated patients with AF followed\u2010up over a long\u2010term period, the novel\n              <jats:styled-content style=\"fixed-case\">ABC<\/jats:styled-content>\n              \u2010stroke score does not offer significantly better predictive performance compared with the\n              <jats:styled-content style=\"fixed-case\">CHA<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n              c score.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.117.006490","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:10:36Z","timestamp":1500595836000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":40,"title":["Long\u2010Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC\u2010Stroke and CHA\n            <sub>2<\/sub>\n            DS\n            <sub>2<\/sub>\n            \u2010VASc Scores"],"prefix":"10.1161","volume":"6","author":[{"given":"Jos\u00e9 Miguel","family":"Rivera\u2010Caravaca","sequence":"first","affiliation":[{"name":"Department of Hematology and Clinical Oncology, Hospital General Universitario Morales Meseguer, Instituto Murciano de Investigaci\u00f3n Biosanitaria (IMIB\u2010Arrixaca), University of Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Rold\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Hematology and Clinical Oncology, Hospital General Universitario Morales Meseguer, Instituto Murciano de Investigaci\u00f3n Biosanitaria (IMIB\u2010Arrixaca), University of Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Asunci\u00f3n","family":"Esteve\u2010Pastor","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Cl\u00ednico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigaci\u00f3n Biosanitaria (IMIB\u2010Arrixaca), CIBERCV, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Vald\u00e9s","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Cl\u00ednico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigaci\u00f3n Biosanitaria (IMIB\u2010Arrixaca), CIBERCV, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Vicente","sequence":"additional","affiliation":[{"name":"Department of Hematology and Clinical Oncology, Hospital General Universitario Morales Meseguer, Instituto Murciano de Investigaci\u00f3n Biosanitaria (IMIB\u2010Arrixaca), University of Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, United Kingdom"},{"name":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mar\u00edn","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Cl\u00ednico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigaci\u00f3n Biosanitaria (IMIB\u2010Arrixaca), CIBERCV, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1584"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw210"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000041"},{"key":"e_1_3_4_5_2","unstructured":"National\u2010Institute\u2010for\u2010Health\u2010and\u2010Care\u2010Excellence . Atrial fibrillation: the management of atrial fibrillation. (clinical guideline 180.). 2014. Available at: http:\/\/guidance.Nice.Org.Uk\/cg180. Accessed February 9 2017."},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309955"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000236840.00467.84"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw054"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.2307\/2531595"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2929"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-8-53"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06295361"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.255182"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.08.049"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2014.12.002"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2015.09.018"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011204"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2014.190"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep41565"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.006286"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.07.093"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.11.082"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.3311"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.01.093"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.113.003338"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.882241"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106439"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-08-0658"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-05-0400"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00741-8"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.117.006490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:31:09Z","timestamp":1715596269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.117.006490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1161\/JAHA.117.006490"],"URL":"https:\/\/doi.org\/10.1161\/jaha.117.006490","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"2017-04-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e006490"}}